Bell Michael Brian 4

What Happened Michael Brian Bell, Chief Financial Officer of Guardant Health, converted/vested restricted stock units (RSUs) on April 1, 2026. The filing shows conversions of 2,084, 3,324 and 7,369 RSU-derived shares (total 12,777 shares). The company withheld 6,869 shares to satisfy tax withholding at $91.15 per share, a withholding value of $626,109. The remaining 5,908 shares were delivered to Mr. Bell. These were vesting/conversion and tax-withholding actions (routine) rather than open-market sales.

Key Details

• Transaction date: April 1, 2026; Form filed April 2, 2026 (appears timely).
• RSU conversions (code M): 2,084 + 3,324 + 7,369 = 12,777 shares converted at $0 exercise price (typical of RSUs).
• Tax withholding (code F): 6,869 shares withheld at $91.15 = $626,109.
• Net shares delivered to insider from this vesting: 5,908 shares.
• Form does not report total shares owned by Mr. Bell after this transaction on its face.
• Footnotes: F1 confirms shares were retained by the company to meet tax withholding (not in excess of tax liability). F2–F5 describe the RSU grants and vesting schedules (grants dated 12/13/2023, 11/8/2024, 3/12/2025 with multi-year vesting and quarterly installments).

Context

• These entries reflect RSU vesting/conversion and routine tax-withholding, not an open-market sale. Code M indicates conversion/exercise of derivative awards (RSUs) and code F indicates shares retained to cover taxes.
• Withholding to satisfy taxes is common and does not necessarily indicate the insider's view on the stock. No 10% owner status or 10b5-1 plan is indicated in the filing.